The Build-Operate-Transfer Law numbered 3996 (the “BOT Law”) determines the scope and framework of investments that can be implemented under the build-operate-transfer (“BOT”) model. While municipalities had the opportunity to carry out various investments with the BOT model under the BOT Law previously, including the environmental projects, with the introduction of Additional Article 3 to the BOT Law on 15 June 2022, a more straightforward method for the environmental pollution prevention investments of the municipalities has been introduced and it paved the way for the rapid completion of these investments.
You may reach the details of the developments introduced by the additional article 3 here.
Share
Related persons
You can contact us for detailed information.
Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
28 January 2025
Recent developments in Turkish data protection law
The end of 2024 and the beginning of 2025 were highly active in terms of developments in data protection legislation in Türkiye. Many…
13 January 2025
New Administrative Fines Regulation For Competition Violations Enters Into Force
The Regulation on Administrative Fines for Restrictive Agreements, Concerted Practices, Decisions, and Abuse of Dominance, which governs…
9 January 2025
Türkiye Strengthens Anti-Money Laundering Standards for Crypto Assets
Following the legal framework established for crypto assets and crypto asset service providers ("CASPs") under the Capital Markets Law No.…
6 January 2025
Thresholds for Initial Public Offerings Increased
As per the decision of the Capital Markets Board (the “CMB”) published in its bulletin dated 31 December 2024, the financial thresholds…
30 December 2024
Legal Briefing on Recent Developments in the Electricity Market
With the Regulation on Aggregation Activities in the Electricity Market, published in the Official Gazette dated 17 December 2024 and…
23 December 2024
Transfer of Marketing Authorisations for Medicinal Products
Under Turkish law, only entities registered in Türkiye are eligible to obtain a marketing authorization (“MA”) for medicinal products for…